ALK and T-cell non-Hodgkin lymphoma: Studies in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) positive (ALK+) T-cell lymphoma, a subgroup of anaplastic large cell lymphoma (ALCL), have implicated the transcription factor STAT3 as a central player in epigenetic regulation (3, 4).